Re: Osteoporosis/Menostar

From: Garry E. Siegel, M.D. (garrys@mindspring.com)
Thu Feb 10 19:49:02 2005


Ron:

Impressively thorough. I would refer to an internist/endocrinologist.

Somebody pointed out that this value, while low, could represent an improvement.

I agree that she MIGHT be an estrogen candidate, with informed consent.

**Is anyone using Menostart, the low dose patch for prevention and treatment of osteoporosis?** If so, are you using progestin, and, if so, how?

Garry

At Thu, 10 Feb 2005, ainsron wrote: >
>Has she been on steroids, or any signs of Cushings Syndrome? You need to
>look for other causes - check serum Calcium to exclude hyperparathyroidism,
>TSH to exclude hyperthyroidism, 25-hydroxyvitamin D to exclude vitamin D
>deficiency and 24 hr urinary calcium to assess malabsorption and renal
>abnormalities. Be sure she is taking 1200-1500 mg Ca and Vit D
>supplementation, 800 IU/d and weight bearing exercise. F/U BMD in 2 years.
>If she is truly taking her Fosamax, she may be a nonresponder, you could
>check a biochemical marker of bone resorption, if it is elevated
>significantly that could prove useful information. There is heterogeneity
>and markers often do not provide a clear-cut answer, but it may give you a
>reason to try another bisphosphonate, i.e. residronate. Teriparatide (human
>recombinant PTH) can be used in women who have failed or are intolerant to
>previous osteoporosis therapy, but it is quite expensive. You could
>consider Evista, clinical trials show decreased incidence of breast CA on
>women on it for 3 years.
>
>Ronald E. Ainsworth
>
>-----Original Message-----
>From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of Elrod
>Darryl G MAJ 48 MDOS/SGOBO
>Sent: Thursday, February 10, 2005 6:35 AM
>To: Multiple recipients of list OB-GYN-L
>Subject: Osteoporosis
>
>I haven't seen many postmenopausal women in the last 4 years, so I'm asking
>for some advice.
>
>I have a 58 yo G3P3 with history of breast cancer and endometrial cancer
>that has been taking fosamax 70mg/wk for her 'prevention of osteoporosis.'
>She has had a mastectomy and TVH/BSO in the past.
>
>This was the first I had seen her, so I ordered a bone density scan since
>she hadn't had one in several years. Her T score was -2.6.
>
>Obviously, she is not a candidate for estrogen therapy.
>
>Now that she is clearly osteoporotic, what other options do I have in her
>treatment?
>
>Thanks,
>
>Glen
>
>D. Glen Elrod, Maj USAF, MC
>
>Obstetrician/Gynecologist
>
>Maternal Child Flight
>
>48 MDOS/SGOBO
>
>UNIT 5210 Box 23
>
>APO, AE 09464
>
>DSN (314) 226-8334
>
>Comm 01638-52-8334
>
>Notice of Confidentiality
>Under the Privacy Act of 1974, you must safeguard all information reflected
>on this Email and, if applicable, all attachments. Disclosure of
>information is IAW AFI 33-119, AFI 33-127, AFI 37-131, AFI 37-132, AFI
>33-219, and PL 93-579"
>This document may contain information covered under the Privacy Act, 5 USC
>552(a), and/or the Health Insurance Portability and Accountability Act (PL
>104-191) and its various implementing regulations and must be protected in
>accordance with those provisions. Healthcare information is personal and
>sensitive and must be treated accordingly. See
><https://sg.usafe.af.mil/HIPAADisclosure.cfm> for full details.

--
Garry E. Siegel, M.D.
Private Practice
Roswell, GA




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Tue Dec 2 04:45:18 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.